Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mele

Showing results (21-30 of 297) with videos related to

Pageof 30
Sort By:
Psychopharmacology|October 1, 1995
Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidanceA Mele, C Castellano, A Oliverio
Annali Dell'Istituto Superiore Di Sanita|January 1, 1995
[Epidemiology and prevention of HCV infection in dialysis centers]L Cialdea, L Sagliocca, A Mele
The Journal of Pharmacy and Pharmacology|May 1, 1994
Reversal of chlorpromazine-induced avoidance depression by the N-methyl-D-aspartate antagonist, dizocilpine, in miceA Mele, M Battaglia, M Sansone
Public Health|July 1, 1988
HBsAg carriers among pregnant women in Italy: results from the screening during a vaccination campaign against hepatitis BT Stroffolini, P Pasquini, A Mele
The Italian Journal of Gastroenterology|July 1, 1991
Hepatitis A in Italy: epidemiology and suggestions for controlA Mele, P Pasquini, A Pana
Progress in Clinical and Biological Research|January 1, 1984
Involvement of endogenous opioid systems in social behavior of individually-housed miceS Puglisi-Allegra, A Mele, S Cabib
Annals of Plastic Surgery|March 1, 1997
Treatment of thromboembolic complications of fulminant meningococcal septic shockJ A Mele, S Linder, A Capozzi
Cellular Immunology|January 1, 1982
Tumor bearer T cells suppress BCG-potentiated antitumor responses II. Characteristics of the efferent phase suppressorE Hawrylko, C A Mele, O Stutman
Neuroscience|March 4, 1998
Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activityA Mele, D N Thomas, A Pert
Annali Dell'Istituto Superiore Di Sanita|January 1, 1987
Epidemiology of hepatitis B in ItalyL Dardanoni, A Mele, M C Polizzi
Pageof 30

Showing results (21-30 of 297) with videos related to

Sort By:
Pageof 30
Psychopharmacology|October 1, 1995
Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidanceA Mele, C Castellano, A Oliverio
Annali Dell'Istituto Superiore Di Sanita|January 1, 1995
[Epidemiology and prevention of HCV infection in dialysis centers]L Cialdea, L Sagliocca, A Mele
The Journal of Pharmacy and Pharmacology|May 1, 1994
Reversal of chlorpromazine-induced avoidance depression by the N-methyl-D-aspartate antagonist, dizocilpine, in miceA Mele, M Battaglia, M Sansone
Public Health|July 1, 1988
HBsAg carriers among pregnant women in Italy: results from the screening during a vaccination campaign against hepatitis BT Stroffolini, P Pasquini, A Mele
The Italian Journal of Gastroenterology|July 1, 1991
Hepatitis A in Italy: epidemiology and suggestions for controlA Mele, P Pasquini, A Pana
Progress in Clinical and Biological Research|January 1, 1984
Involvement of endogenous opioid systems in social behavior of individually-housed miceS Puglisi-Allegra, A Mele, S Cabib
Annals of Plastic Surgery|March 1, 1997
Treatment of thromboembolic complications of fulminant meningococcal septic shockJ A Mele, S Linder, A Capozzi
Cellular Immunology|January 1, 1982
Tumor bearer T cells suppress BCG-potentiated antitumor responses II. Characteristics of the efferent phase suppressorE Hawrylko, C A Mele, O Stutman
Neuroscience|March 4, 1998
Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activityA Mele, D N Thomas, A Pert
Annali Dell'Istituto Superiore Di Sanita|January 1, 1987
Epidemiology of hepatitis B in ItalyL Dardanoni, A Mele, M C Polizzi
Pageof 30